Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 april 2022NewsCorporateFees EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 marts 2022NewsHuman Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 marts 2022NewsHumanCorporateClinical trials EU recommendations for 2022-2023 seasonal flu vaccine composition 29 marts 2022NewsHumanVaccines EMA starts rolling review of COVID-19 Vaccine HIPRA (PHH-1V) 29 marts 2022NewsHumanCOVID-19Vaccines New gene therapy to treat adult patients with multiple myeloma 25 marts 2022NewsHumanMedicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022 25 marts 2022NewsHumanCOVID-19Medicines EMA recommends authorisation of COVID-19 medicine Evusheld 24 marts 2022NewsHumanCOVID-19Data on medicines EMA Management Board: highlights of March 2022 meeting 18 marts 2022NewsCorporate Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 March 2022 18 marts 2022NewsVeterinaryMedicines 1 … 44 45 46 47 48 Page 48 of 380 49 50 51 52 … 380
Regulatory information – 0.3% and 5.3% increase in general fees from 1 April 2022 1 april 2022NewsCorporateFees
EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice 31 marts 2022NewsHuman
Advice to sponsors on managing the impact of the war in Ukraine on clinical trials 30 marts 2022NewsHumanCorporateClinical trials
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022 25 marts 2022NewsHumanCOVID-19Medicines
EMA recommends authorisation of COVID-19 medicine Evusheld 24 marts 2022NewsHumanCOVID-19Data on medicines
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 March 2022 18 marts 2022NewsVeterinaryMedicines